FDC Limited has scheduled its 86th Annual General Meeting (AGM) for Thursday, September 24, 2026, at 10:00 am. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means.

The primary agenda includes receiving, considering, and adopting the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. Shareholders will also vote on the re-appointment of Executive Director Mr. Ashok Anand Chandavarkar, who retires by rotation.

Special Business Items

The Board seeks ratification of the remuneration payable to the Cost Auditor for the Financial Year 2026–27. M/s. GMVP & Associates LLP was appointed to conduct the audit of cost records. The proposed remuneration is ₹4,25,000 plus applicable taxes and reimbursement of out-of-pocket expenses.

Key Dates and Voting Details

Members holding shares as on the cut-off date are eligible to vote. The facility for remote e-voting is provided by National Securities Depository Limited (NSDL). Institutional shareholders must submit scanned copies of relevant board resolutions or authority letters to the Scrutinizer.

Director Re-appointment

Mr. Ashok Anand Chandavarkar, who has been associated with the company since March 31, 1987, is seeking re-appointment. He holds a Bachelor of Engineering degree in Mechanical Engineering and brings approximately four decades of experience in the pharmaceutical industry. He currently oversees procurement functions and general management.

Shareholder Instructions

The Annual Report for FY25-26 is available electronically on the company website. Members are advised to update their bank details and KYC with their Depository Participants or the Registrar and Transfer Agent, MUFG Intime India Private Limited, to ensure timely receipt of dividends via electronic mode. Physical dividend warrants will no longer be issued.

FDC has secured an interim stay from the Delhi High Court on a product label notice issued by the Food Safety and Standards Authority of India (FSSAI). The order, received on August 26, 2026, halts enforcement of the directive concerning alleged mislabeling.

Court intervention in FSSAI labelling dispute

The High Court's interim order suspends immediate action arising from the notice while the writ petition remains before the court. Crucially, the court has allowed the company eight months to exhaust its existing stock bearing the descriptors 'electrolyte' or 'electrolyte drink' and to make required changes to the labels.

This development provides temporary relief from the regulatory directive, which stemmed from a seizure of stock by FSSAI Maharashtra. The company had previously filed a writ petition seeking relief against the impugned notice from FSSAI New Delhi.

Background on the regulatory notice

The contravention relates to the mislabeling of products. In its disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, FDC stated there is no material adverse impact on its financials, operations, or other activities due to this order.

The company disclosed that it has been given time to exhaust current inventory and update labels, mitigating potential disruption to sales during the pendency of the case.